...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Notes

Zenith Capital Corp.     Apr 6 2023     15:01:09 ET     Interim financial statements/report - English    PDF     570 K 

Share
New Message
Please login to post a reply